Skip to content
Screener

Insulet PODD Interest Income

Interest Income at other companies

Beta Bionics logo
Beta BionicsBBNX
$2.18M-27.6%
Opko Health logo
Opko HealthOPK
$3.22M-2.0%
Omada Health logo
Omada HealthOMDA
$1.76M+104%
Abbott logo
AbbottABT
$52M-26.8%
AptarGroup logo
AptarGroupATR
$3.64M+29.4%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$3.8M+5.6%

Other financials

Income statement

See full
Revenue$801.7M+23.5%
Gross profit$562.6M+24.4%
Operating income$129.7M+7.1%
Net income$95.0M+322%
EPS (diluted)$1.37+328%

Balance sheet

See full
Cash & equivalents$534.9M-52.3%
Total debt$974.7M-47.6%
Total equity$1.4B-2.8%
Total assets$3.2B-8.8%

Cash flow

See full
Operating cash flow$88.4M-55.0%
CapEx$32.5M+74.7%
Free cash flow$55.9M-68.6%

Valuation

See full
Market cap$9.79B-54.4%
Enterprise value$10.23B-53.9%
P/E26.1×-64.8×
P/S3.2×-5.9×

Profitability

See full
Gross margin71.1%+0.3pp
Operating margin16.9%-0.4pp
Net margin12.3%+2.3pp
FCF margin9.6%-7.5pp

Returns & leverage

See full
Return on equity26%+6.8pp
Debt / equity0.7×-0.6×
Current ratio2.5×+0.2×

Where this comes from

Reported directly by Insulet in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The source filing: Insulet’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001145197-26-000169
(in millions, except share and per share data)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Selling, general and administrative expenses344.8257.7662.1518.4
Operating income129.7121.1251.8209.9
Interest expense(13.5)(19.6)(28.2)(28.8)
Interest income3.610.18.520.3
Loss on extinguishment of debt(84.4)(123.9)
Other (expense) income, net(1.1)1.3(0.4)(0.9)
Income before income taxes118.728.4231.776.5
Income tax expense(23.7)(5.9)(45.6)(18.6)

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Insulet's interest income?
Insulet (PODD) reported interest income of $3.6M in Q2 2026.
How has Insulet's interest income changed year-over-year?
Insulet's interest income decreased by 64.4% year-over-year, from $10.1M to $3.6M.
What is the long-term trend for Insulet's interest income?
Over 3 years (2021 to 2025), Insulet's interest income has grown at a 310.9% compound annual growth rate (CAGR), from $500K to $34.7M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.

Ask your AI about Insulet's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude